Nifty Alpha Low-Volatility 30 PB	5.5
Nifty Alpha Low-Volatility 30 PE	33.3
Nifty Alpha Low-Volatility 30 DIV	1.1
Nifty Alpha Low-Volatility 30 EPS	805.4

Nifty Alpha Low-Volatility 30 Corporate Filings & Announcements

Latest corporate announcements and filings from Nifty Alpha Low-Volatility 30 on BSE

Search Inside the pdf :

Dr. Reddy's Laboratories Ltd.

22 Sep 2025, 05:42PM

1301.40

-1.54%

Company Update

Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release

pdf

Tata Consultancy Services Ltd.

22 Sep 2025, 04:57PM

3073.80

-3.01%

Corp. Action

Tata Consultancy Services Ltd - 532540 - Corporate Action-Board to consider Dividend

BSE India

The second interim dividend, if declared, shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Wednesday, October 15, 2025, which is the Record Date fixed for the purpose.

pdf

Sun Pharmaceutical Industries Ltd.

22 Sep 2025, 04:46PM

1644.00

-0.72%

SAST

Sun Pharmaceutical Industries Ltd - 524715 - Closure of Trading Window

BSE India

Trading Window Closure for Quarter and half year ended 30 September 2025

pdf

Tata Consultancy Services Ltd.

22 Sep 2025, 04:46PM

3073.80

-3.01%

Board Meeting

Tata Consultancy Services Ltd - 532540 - Board Meeting Intimation for Approval Of Financial Results And …

BSE India

Tata Consultancy Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Tata Consultancy Services Limited is scheduled to be held on Thursday, October 9, 2025, inter alia to: i. approve and take on record the audited standalone financial results of the Company under Indian Accounting Standards (Ind AS) for the quarter and six-month period ending September 30, 2025; ii. approve and take on record the audited consolidated financial results of the Company and its subsidiaries under Ind AS for the quarter and six-month period ending September 30, 2025; and iii. consider declaration of second interim dividend to the equity shareholders.

pdf

Dr. Reddy's Laboratories Ltd.

22 Sep 2025, 04:21PM

1301.40

-1.54%

Company Update

Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copies of Newspaper Publications

pdf

Dr. Reddy's Laboratories Ltd.

22 Sep 2025, 03:59PM

1301.40

-1.54%

SAST

Dr Reddys Laboratories Ltd - 500124 - Closure of Trading Window

BSE India

Initmation of Board meeting and closure of trading window

pdf

Dr. Reddy's Laboratories Ltd.

22 Sep 2025, 03:57PM

1301.40

-1.54%

Board Meeting

Dr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation for Approval Of The Unaudited Standalone …

BSE India

Dr Reddys Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial results of the Company for the quarter ending September 30, 2025

pdf